Related Experiment Videos
Daily single-dose gentamicin therapy in experimental pyelonephritis
Abstract:
The therapeutic efficacy of gentamicin given once or three times a day was compared in a model of experimental renal infection in rats. The same amount of gentamicin given either in a single injection or three injections a day produced no statistically significant difference in the treatment of incipient infection. The effect of this mode of administration on advanced infection depended on the length of the therapy. After five days, administration of the same dose given in a single injection or three injections did not result in significant differences. After ten days the therapy proved more effective when gentamicin was injected three times a day. In comparison a single daily dose, amounting to two thirds of the total dose when given three times a day every eight hours, revealed after five days of therapy a statistically significantly lower bacterial count in the kidney than three daily injections of gentamicin.
Insights
Gentamicin dosing frequency showed no difference for early kidney infections. For advanced infections, three daily gentamicin injections were more effective than a single dose after ten days.
Area of Science:
- Pharmacology
- Nephrology
- Infectious Diseases
Background:
- Gentamicin is a critical antibiotic for treating bacterial infections.
- Optimizing gentamicin dosing regimens is essential for maximizing therapeutic efficacy and minimizing toxicity.
- Renal infections require careful consideration of antibiotic delivery to ensure adequate drug concentration at the site of infection.
Purpose of the Study:
- To compare the therapeutic efficacy of once-daily versus thrice-daily gentamicin administration.
- To evaluate the impact of dosing frequency on gentamicin's effectiveness in experimental renal infections in rats.
- To determine if the duration of therapy influences the optimal gentamicin dosing strategy.
Main Methods:
- An experimental model of renal infection was established in rats.
- Gentamicin was administered either once daily or three times daily at equivalent total daily doses.
- Bacterial counts in the kidney were assessed after five and ten days of treatment.
- A separate comparison involved a single daily dose (two-thirds of the total thrice-daily dose) versus thrice-daily injections.
Main Results:
- For incipient renal infections, no statistically significant difference in efficacy was observed between once-daily and thrice-daily gentamicin administration.
- In advanced infections, the difference in efficacy between once-daily and thrice-daily dosing became apparent after ten days, with thrice-daily administration being more effective.
- A single daily dose of gentamicin, amounting to two-thirds of the total thrice-daily dose, resulted in significantly lower kidney bacterial counts than thrice-daily injections after five days.
Conclusions:
- Dosing frequency of gentamicin does not significantly impact treatment outcomes for early-stage renal infections.
- For advanced renal infections, a thrice-daily gentamicin dosing regimen is more effective than once-daily administration, particularly after prolonged treatment (ten days).
- Further research may be warranted to explore optimal gentamicin dosing strategies, considering dose reduction and frequency for specific infection stages.